NasdaqCM - Nasdaq Real Time Price • USD
OptimizeRx Corporation (OPRX)
At close: May 28 at 4:00 PM EDT
After hours: May 28 at 4:11 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | -0.05 | 0.1 | 0.3 | 0.48 |
| Low Estimate | -0.09 | 0.06 | 0.26 | 0.43 |
| High Estimate | 0.01 | 0.18 | 0.35 | 0.58 |
| Year Ago EPS | -0.01 | 0.09 | 0.26 | 0.3 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 6 | 6 |
| Avg. Estimate | 20.21M | 25.69M | 101.47M | 113.04M |
| Low Estimate | 19.3M | 25M | 100.07M | 110.07M |
| High Estimate | 20.87M | 27.8M | 104M | 116.37M |
| Year Ago Sales | -- | 15.15M | 71.52M | 101.47M |
| Sales Growth (year/est) | -- | 69.60% | 41.90% | 11.40% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.02 | 0.02 | 0.32 | -0.13 |
| EPS Actual | -0.01 | 0.09 | 0.26 | -0.11 |
| Difference | 0.01 | 0.07 | -0.06 | 0.02 |
| Surprise % | 50.00% | 350.00% | -18.80% | 15.40% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.05 | 0.1 | 0.3 | 0.48 |
| 7 Days Ago | -0.05 | 0.1 | 0.32 | 0.5 |
| 30 Days Ago | -0.02 | 0.14 | 0.41 | 0.59 |
| 60 Days Ago | -0.02 | 0.06 | 0.32 | 0.48 |
| 90 Days Ago | -0.02 | 0.04 | 0.34 | 0.49 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | 1 | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | OPRX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -400.00% | -- | -- | 7.90% |
| Next Qtr. | 11.10% | -- | -- | 10.20% |
| Current Year | 15.40% | -- | -- | 4.80% |
| Next Year | 60.00% | -- | -- | 12.50% |
| Next 5 Years (per annum) | 11.50% | -- | -- | 11.27% |
| Past 5 Years (per annum) | 29.26% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | JMP Securities: Market Outperform to Market Outperform | 5/15/2024 |
| Maintains | Stifel: Buy to Buy | 5/15/2024 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 4/16/2024 |
| Initiated | JMP Securities: Market Outperform | 4/4/2024 |
| Maintains | Stifel: Buy to Buy | 4/1/2024 |
| Reiterates | RBC Capital: Outperform to Outperform | 4/1/2024 |
Related Tickers
LFMD LifeMD, Inc.
7.77
-0.89%
CMAX CareMax, Inc.
2.8900
+5.47%
PHR Phreesia, Inc.
22.61
-0.09%
COP.DE CompuGroup Medical SE & Co. KGaA
27.52
0.00%
TALK Talkspace, Inc.
2.8300
-1.05%
OMCL Omnicell, Inc.
32.40
-0.70%
HSTM HealthStream, Inc.
27.11
+0.11%
NRC National Research Corporation
30.12
-0.73%
DOCS Doximity, Inc.
28.70
+3.13%
AUGX Augmedix, Inc.
1.1000
-3.51%